Eyes on post-COVID business recovery
–Solid 2Q23 earnings quality; Eyes on upmarket
2023 Investor Day： All eyes on profitability and smart EV business upside
China Technology–Global fabless／IDM 2Q23 wrap： expect continued inventory correction for non-AI players; All eyes on NVDA 3Q23E guidance
–2Q rev／np +1%／3%; all eyes on cost savings
Eyes on next steps of orelabrutinib for MS
China Technology–Global fabless／IDM 3Q23 wrap： PC／SP recovery, auto／ industrial mixed; Eye on Edge AI as new growth driver
Weather short-term headwinds in 2Q24; eyes on 2H24E recovery
Mid-term evaluation of the Global Strategy to Eliminate Yellow Fever Epidemics (EYE) 2017 - 2026 Volume 1: Report - January 2023
Tunisia’s Economy in the Eye of the Storm
公众号
小程序
社群
公众号小程序社群